Mixed hematopoietic chimerism induces long-term tolerance to cardiac allografts in miniature swine

Ann Thorac Surg. 2000 Jul;70(1):131-8; discussion 138-9. doi: 10.1016/s0003-4975(00)01564-2.


Background: Tolerance to cardiac allografts has not been achieved in large animals using methods that are readily applicable to human recipients. We investigated the effects of mixed hematopoietic chimerism on cardiac allograft survival and chronic rejection in miniature swine

Methods: Recipients were T-cell depleted using a porcine CD3 immunotoxin, and each received either of two nonmyeloablative preparative regimens previously demonstrated to permit the establishment of stable mixed hematopoietic chimerism across MHC-matched, minor antigen-mismatched histocompatibility barriers. Five to 12 months after the chimerism was induced, hearts from the original cell donors were heterotopically transplanted into the stable mixed chimeras.

Results: Cardiac allografts transplanted into untreated recipients across similar minor antigen barriers were rejected within 44 days (within 21, 28, 35, 39, 44 days among individual study subjects). In contrast, hearts transplanted into the mixed chimeras were all accepted long term ( > 153, > 225, > 286, > 362 days) without immunosuppressive drugs and developed minimal vasculopathy.

Conclusions: Mixed hematopoietic chimerism, established in miniature swine using clinically relevant, non-myeloablative conditioning regimens, permits long-term cardiac allograft survival without chronic immunosuppressive therapy, significant vasculopathy, or graft-versus-host disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • CD3 Complex / immunology
  • Graft Rejection / immunology*
  • Graft Survival / immunology*
  • Heart Transplantation / immunology*
  • Hematopoiesis / immunology*
  • Hematopoietic Stem Cells / immunology
  • Swine
  • Time Factors
  • Transplantation Chimera / immunology*
  • Transplantation Immunology*


  • CD3 Complex